Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0A4GE
|
||||
| Former ID |
DNC013486
|
||||
| Drug Name |
1,2,3,7,12,12a-hexahydro-1-aza-pleiadene-5,6-diol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528616] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C17H17NO2
|
||||
| Canonical SMILES |
C1CNC2CC3=CC=CC=C3CC4=C2C1=CC(=C4O)O
|
||||
| InChI |
1S/C17H17NO2/c19-15-9-12-5-6-18-14-8-11-4-2-1-3-10(11)7-13(16(12)14)17(15)20/h1-4,9,14,18-20H,5-8H2
|
||||
| InChIKey |
SVRDMCXMTWERHI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [528616] | |
| Dopamine D1 receptor | Target Info | Inhibitor | [528616] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Dopamine receptor mediated signaling pathway | |||||
| Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
| PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.